JMP Securities Upgrades BioCryst Pharma (BCRX) to Market Outperform
Get Alerts BCRX Hot Sheet
Price: $9.34 -0.43%
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Rating Summary:
17 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Join SI Premium – FREE
JMP Securities upgraded BioCryst Pharma (NASDAQ: BCRX) from Market Perform to Market Outperform with a price target of $3.00.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $2.04 yesterday.
For an analyst ratings summary and ratings history on BioCryst Pharma click here. For more ratings news on BioCryst Pharma click here.
Shares of BioCryst Pharma closed at $2.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioCryst to Report Second Quarter 2026 Financial Results on August 5
- PhillipCapital Upgrades Bharat Petroleum (BPCL:IN) to Neutral (3)
- JPMorgan Upgrades James Hardie Industries (JHX:AU) (JHX) to Overweight
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share